A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference17 articles.
1. Global cancer statistics;Parkin;CA Cancer J. Clin.,1999
2. Treatment of advanced epithelial ovarian cancer: past, present and future;Hoskins;Crit. Rev. Oncol. Hematol.,1995
3. Surgical management of ovarian cancer;Mutch;Semin. Oncol.,2002
4. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study;Ozols;J. Clin. Oncol.,2003
5. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Engl. J. Med.,1996
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer;Journal of Clinical Oncology;2010-09-20
2. CXCL12 chemokine genotypes as predictive biomarkers of ovarian cancer outcome;Molecular Medicine Reports;2008
3. A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors;Cancer Chemotherapy and Pharmacology;2007-12-06
4. Role of Gemcitabine in the Treatment of Ovarian Cancer;Women's Health;2007-05
5. The Role of Gemcitabine in First-Line Treatment of Advanced Ovarian Carcinoma;Seminars in Oncology;2006-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3